Parkinson's Disease (PD) is nowadays considered as a complex clinical condition in which motor symptoms coexist with several non-motor symptoms. A growing body of literature has addressed non-motor symptoms in PD [1] , that are progressively being recognized as a potential source of distress for patients and their families, even greater than that imposed by the well-known motor impairments [2] [3] [4] .
problems, particularly the delusions, are among the most important precipitants for nursing home placement, and are related with a poor prognosis (in terms of development of dementia and of increased mortality). There is considerable debate about the genesis of psychotic symptoms and their treatment options, since reduction of medication for PD motor symptoms and use of specific drug treatment for psychosis can both worsen motor function. At the moment there is level A evidence to support use of clozapine in PD patients with psychosis, with or without dementia, whereas quetiapine has been recommended for "consideration," since double blind placebo controlled trials have demonstrated safety but not efficacy.
The hypotheses about the genesis of VH in PD and Lewy body dementias have been reviewed by Onofrj et al. [8] . Classically, occurrence of VH in PD has been ascribed to visual disorders, cognitive deficits, Rapid Eye Movement (REM) Sleep Intrusions, dysfunctions of top down or bottom up visual pathways, or neurotransmitter imbalance [9] [10] [11] [12] [13] [14] . As Onofrj et al. [8] underlined, more recent hypotheses introduce, among the possible mechanisms of VH, the role of attention networks and of the Default Mode Network (DMN), a network that is inhibited during attentional tasks and becomes active during rest and self referential imagery. Persistent DMN activity during active tasks with dysfunctional imbalance of dorsal and ventral attentional networks might represent a new hypothesis to explain the genesis of VH in PD.
A brief report enclosed in the present issue by Cristinzio et al. [15] specifically tested the efficiency of three attentional systems (spatial orienting, phasic alerting and executive control) in patients with Parkinson's disease (PD), by means of a task employing acoustic tones to modulate phasic alertness. PD patients were generally slower than age-matched controls, but they showed a similar pattern of effects and interactions. In particular, as in normal subjects, PD patients' responses showed a normal congruency effect (thought to reflect executive control), and were faster for valid visual cues than with invalid or no cues (thus demonstrating a normal orienting effect), and when acoustic tones preceded the target (with a higher-than-normal alerting effect). Therefore, Cristinzio et al. [15] did not detect any selective impairment of the attentional networks in PD patients without dementia and without VH, but observed a general slowing of responses in PD, that was at least partially ascribed to bradykinesia. Further specifically designed studies are necessary to demonstrate the behavioral correlates of putative attentional defects in the genesis of VH.
A possible role of cognitive alterations (e.g. attentional or executive impairments) has been hypothesized also for the genesis of other psychological disorders in PD. In the present issue a review by Santangelo et al. [16] specifically addressed apathy, i.e. lack of motivation, that is associated with decreased daily function, and increased stress for families [5, 17] . Apathy has been traditionally considered as a symptom of psychiatric disorders, such as major depression and schizophrenia, but more recently it has been recognized as a specific neuropsychiatric syndrome associated with neurodegenerative diseases such as PD. The overlap between apathy and depression can cause substantial difficulties in identifying and distinguishing the two syndromes [18, 19] . Although most studies found an association between apathy and depression in PD patients, and between apathy and anhedonia, "pure" apathy can be recognized in PD when specific diagnostic tools are employed [20, 21] . As underlined by Santangelo et al. [16] , apathy and depression can dissociate in PD, and are characterized by different features: depression includes sadness and negative thoughts about the self, while diagnosis of apathy rests on lack of initiation and lack of effort, but not on negative self or event appraisal. Although neuroimaging studies do not provide a unique anatomic pattern, several data suggest that the ventromedial prefrontal cortex and the basal ganglia connected through frontal-subcortical circuits, are particularly involved in the genesis of apathy. This hypothesis about the neural bases of apathy received support from neuropsychological studies highlighting the presence of frontal/executive disorders in PD patients with "pure apathy" (i.e., non-demented, non-depressed patients with high scores on specific questionnaires for apathy) [22, 23] . An original research paper by Grossi et al. in the present issue [24] verified that this specific relationship holds true in both demented PD patients and patients with Alzheimer's disease. Actually, Grossi et al. [24] explored memory, visuospatial and executive functions in patients affected by the two neurodegenerative diseases; the authors also used specific behavioral rating scales and an inventory developed to measure severity of apathy on clinical basis, the newly proposed Clinical Judgment for Apathy Syndrome. The results showed that apathetic patients with both forms of dementia showed a common neuropsychological and behavioral picture, characterized by impairment on frontal tasks, thus strongly supporting the existence of an 'apathetic syndrome', characterized by specific cognitive and psychological symptoms.
A further research paper enclosed in the present issue by Costa et al. [25] explored the impact of dysexecutive defects on the ability to understand the mental states of others, as assessed by Theory of Mind (ToM) tasks in non-demented PD patients. Dysexecutive PD patients performed less accurately on a faux pas recognition test administered in written modality with respect to PD patients without dysexecutive impairment; this latter group of PD patients performed as accurately as the normal control group. According to the authors, these results would demonstrate that PD is not necessarily associated with ToM impairments, but that only PD patients with executive defects show an impaired ability to understand others' mental state, in agreement with recent findings showing a significant association between impaired cognitive aspect of ToM abilities and frontal dysfunction in PD patients without dementia [26] .
Besides the relationships between apathy and dysexecutive impairment, another possible correlate of apathy has been explored by Bogdanova and CroninGolomb in the present issue [27] . In fact the authors aimed at exploring the relation between apathy and alexithymia, an impairment of affective and cognitive emotional processing, mainly characterized by difficulties in identifying and describing own feelings, and increasingly recognized as a non-motor symptom in PD [28, 29] . Bogdanova and Cronin-Golomb administered rating scales assessing neuropsychiatric status, including alexithymia, apathy, and depression, and a series of neuropsychological tests to non-demented PD patients and to a group of matched normal control adults. As expected, PD patients showed more alexithymia than normal controls, and there was a significant association between alexithymia and disease stage. Moreover, alexithymia was associated with performance on non-verbally mediated measures of executive and visuospatial function, but not on verbally mediated tasks, thus suggesting the possible association of alexithymia with non-verbal cognition, i.e. mainly with right hemisphere processes, in PD. Incidentally, Bogdanova and Cronin-Golomb did not find any significant correlation between cognition and ratings of apathy, apparently in contrast with the previous reviewed neuropsychological evidence. However, since alexithymia was correlated with severity of apathy in this sample, the relationships among alexithymia, apathy and dysexecutive functions remain to be fully elucidated.
A further kind of behavioral symptoms in PD, the impulse control disorders (ICDs), have been addressed by Bugalho and Oliveira-Maia in the present issue [30] . ICDs are characterized by an inappropriate drive to conduct repetitive behaviours that are usually socially inadequate or result in harmful consequences. In their review Bugalho and Oliveira-Maia discussed the association of ICDs with psychiatric co-morbidities such as obsessive-compulsive disorder and with dopamine related side effects, such as hallucinations and dyskinesias, the relationship with executive cognitive dysfunction [31, 32] , and the neural underpinnings of ICDs in PD. Taking into account evidence gathered from animal models, Bugalho and Oliveira-Maia proposed an explanation of the genesis of ICDs in PD specifically based on an alteration of corticostriatal control of goal directed and habitual actions.
Two interesting examples of ICDs in PD are provided by two case reports included in the present issue. Vitale et al. [33] described a PD patient who developed an unusual, severe, repetitive behavior characterized by an irrepressible need to drum and beat percussion instruments (compulsive drumming). This compulsive behavior was apparently related to introduction of pramipexole, and was not associated to a pattern of chronic inappropriate overuse of dopaminergic medication or other psychiatric symptoms. Therefore, compulsive drumming might be considered a distinct manifestation of punding, i.e. of aimless stereotyped behaviors performed for long periods of time at the expenses of other habitual daily activities [34] in PD. Solla et al. [35] reported, instead, on the dopamine dysregulation syndrome (DDS), an addiction-like behavioral disturbance developed by a small proportion of PD patients under chronic dopamine replacement therapy. This behavioral disorder is characterized by the increase of doses beyond those required for motor control, and its management remains difficult; thus, early recognition and careful monitoring of at-risk individuals are crucial. Solla et al. [35] described two PD patients with a previous unsatisfactory switching from an immediate release to an extended release pramipexole formulation who developed DDS. According to the authors an unsatisfactory switching to extended-release formulations of dopamine agonists in PD patients should be regarded as a potential index to identify individuals at-risk for DDS development.
To enrich the complex relationships among psychiatric, behavioral and cognitive disorders in PD, it is important to consider that PD patients may present with a personality profile characterized by low Novelty Seeking and high Harm Avoidance [36] . This profile can be identified as the disease emerges, which raises the question whether these traits correlate with more fundamental neuropsychological and emotional disturbances. In the present issue Koerts et al. [37] searched for neuropsychological and emotional correlates of Novelty Seeking, Harm Avoidance and of two other personality traits that are often considered in PD, i.e. Reward Dependence and Persistence. By means of a specific assessment tool, the Temperament and Character Inventory [38] , Koerts et al. [37] observed a higher Harm Avoidance in PD patients than in healthy participants, whereas the two groups did not differ for Novelty Seeking, Reward Dependence and Persistence. In PD patients Harm Avoidance was predicted by symptoms of depression, Reward Dependence by cognitive flexibility, and Persistence by divergent thinking and inhibition. On these bases Koerts et al. [37] suggested that cognition and emotion are selectively related to personality traits in PD, thus implying that alterations in personality, cognition and emotion in PD would not be independent from each other.
Taken together, the papers enclosed in the present issue underline the current efforts to comprehend the nature of the relationships among cognitive, behavioral and psychiatric non-motor symptoms in PD. Further studies are necessary to verify whether the different symptoms share common pathogenetic mechanisms and whether they can be traced back to specific molecular alterations. We hope that the present issue will provide a valuable contribution towards this goal.
